These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. P75 neurotrophin receptor in the nucleus basalis of meynert in relation to age, sex, and Alzheimer's disease. Salehi A; Ocampo M; Verhaagen J; Swaab DF Exp Neurol; 2000 Jan; 161(1):245-58. PubMed ID: 10683291 [TBL] [Abstract][Full Text] [Related]
24. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function. Gibbs RB Exp Neurol; 1998 Jun; 151(2):289-302. PubMed ID: 9628764 [TBL] [Abstract][Full Text] [Related]
25. Arginine-vasopressin and vasointestinal polypeptide rhythms in the suprachiasmatic nucleus of the mouse lemur reveal aging-related alterations of circadian pacemaker neurons in a non-human primate. Cayetanot F; Bentivoglio M; Aujard F Eur J Neurosci; 2005 Aug; 22(4):902-10. PubMed ID: 16115213 [TBL] [Abstract][Full Text] [Related]
26. Increased neuronal metabolic activity and estrogen receptors in the vertical limb of the diagonal band of Broca in Alzheimer's disease: relation to sex and aging. Ishunina TA; Swaab DF Exp Neurol; 2003 Sep; 183(1):159-72. PubMed ID: 12957499 [TBL] [Abstract][Full Text] [Related]
27. Decreased neuronal activity in the nucleus basalis of Meynert in Alzheimer's disease as suggested by the size of the Golgi apparatus. Salehi A; Lucassen PJ; Pool CW; Gonatas NK; Ravid R; Swaab DF Neuroscience; 1994 Apr; 59(4):871-80. PubMed ID: 8058125 [TBL] [Abstract][Full Text] [Related]
28. Arginine vasopressin (AVP) depletion in neurons of the suprachiasmatic nuclei affects the AVP content of the paraventricular neurons and stimulates adrenocorticotrophic hormone release. Gomez F; Chapleur M; Fernette B; Burlet C; Nicolas JP; Burlet A J Neurosci Res; 1997 Nov; 50(4):565-74. PubMed ID: 9404718 [TBL] [Abstract][Full Text] [Related]
29. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease. Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017 [TBL] [Abstract][Full Text] [Related]
30. The cholinergic system, circadian rhythmicity, and time memory. Hut RA; Van der Zee EA Behav Brain Res; 2011 Aug; 221(2):466-80. PubMed ID: 21115064 [TBL] [Abstract][Full Text] [Related]
31. Effects of aging and genotype on circadian rhythms, sleep, and clock gene expression in APPxPS1 knock-in mice, a model for Alzheimer's disease. Duncan MJ; Smith JT; Franklin KM; Beckett TL; Murphy MP; St Clair DK; Donohue KD; Striz M; O'Hara BF Exp Neurol; 2012 Aug; 236(2):249-58. PubMed ID: 22634208 [TBL] [Abstract][Full Text] [Related]
32. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms]. Šaponjić J Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729 [TBL] [Abstract][Full Text] [Related]
33. Hippocampal estrogen receptor-alpha splice variant TADDI in the human brain in aging and Alzheimer's disease. Ishunina TA; Swaab DF Neuroendocrinology; 2009; 89(2):187-99. PubMed ID: 18815440 [TBL] [Abstract][Full Text] [Related]
34. Isolation of neural precursor cells from Alzheimer's disease and aged control postmortem brain. Lovell MA; Geiger H; Van Zant GE; Lynn BC; Markesbery WR Neurobiol Aging; 2006 Jul; 27(7):909-17. PubMed ID: 15979211 [TBL] [Abstract][Full Text] [Related]
35. Changes in metabolic activity and estrogen receptors in the human medial mamillary nucleus: relation to sex, aging and Alzheimer's disease. Ishunina TA; Kamphorst W; Swaab DF Neurobiol Aging; 2003 Oct; 24(6):817-28. PubMed ID: 12927764 [TBL] [Abstract][Full Text] [Related]
36. Decreased MT1 melatonin receptor expression in the suprachiasmatic nucleus in aging and Alzheimer's disease. Wu YH; Zhou JN; Van Heerikhuize J; Jockers R; Swaab DF Neurobiol Aging; 2007 Aug; 28(8):1239-47. PubMed ID: 16837102 [TBL] [Abstract][Full Text] [Related]
37. Effects of water deprivation on neurokinin B production by the arginine-vasopressin neurons of hypothalamic paraventricular and supraoptic nuclei. Hatae T; Nakayama Y; Kawano H; Masuko S Fukuoka Igaku Zasshi; 2001 Apr; 92(4):89-98. PubMed ID: 11411093 [TBL] [Abstract][Full Text] [Related]
38. Pineal clock gene oscillation is disturbed in Alzheimer's disease, due to functional disconnection from the "master clock". Wu YH; Fischer DF; Kalsbeek A; Garidou-Boof ML; van der Vliet J; van Heijningen C; Liu RY; Zhou JN; Swaab DF FASEB J; 2006 Sep; 20(11):1874-6. PubMed ID: 16818472 [TBL] [Abstract][Full Text] [Related]
39. Circadian modulation of osmoregulated firing in rat supraoptic nucleus neurones. Trudel E; Bourque CW J Neuroendocrinol; 2012 Apr; 24(4):577-86. PubMed ID: 22330181 [TBL] [Abstract][Full Text] [Related]
40. Reduction of scale invariance of activity fluctuations with aging and Alzheimer's disease: Involvement of the circadian pacemaker. Hu K; Van Someren EJ; Shea SA; Scheer FA Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2490-4. PubMed ID: 19202078 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]